Breast cancer aftercare and follow up and program

Not Applicable

• Conditions: Malignant neoplasm of breast; Quality of life and treatment consequences after breast cancer; C50

• Registration Number: DRKS00028840
• Lead Sponsor: niversitätsklinikum Würzburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 933

Inclusion Criteria

End of curative primary treatment; consent to participation

Exclusion Criteria

metastatic breast carcinoma (palliative therapy approach); lack of digital infrastructure; participation in another structured follow-up program with an intervention via digital application

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life: Registration of change in health-related disease-specific quality of life measured by standardized questionnaires: EORTC QLQ-C30 and EORTC QLQ-BR23. Data is collected at 0 and 12 months after inclusion.<br><br>Objectives of the pilot study are feasibility of recruitment, comprehensiveness and completion of data collection and acceptability of intervention assessed by questionnaire and qualitative interview.

Secondary Outcome Measures

Name	Time	Method
Identification of treatment adherence; treatment consequences (e.g., fatigue, neurotoxicity, cardiotoxicity); psychological comorbidities (e.g., anxiety, depression, cognitive impairment); follow-up standards according to guideline; participation in work life and activities of daily living; rehospitalization; progression free survival; patient satisfaction; follow-up costs in the first year (health economic evaluation).